Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA)

Historical Holders from Q3 2024 to Q2 2025

Symbol
KAPA on NYSE
CUSIP
48301N104
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
17.7M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
219K
Holdings value
$173K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
10
Number of buys
8
Number of sells
-3
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 4.99% -50% $1.04M -$958K 885K -47.9% Armistice Capital, LLC Jun 30, 2025

Institutional Holders of Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 219K $173K -$1.3M $0.71 10
2025 Q1 1.58M $1.46M +$858K $0.94 8
2024 Q4 407K $618K +$549K $1.52 5
2024 Q3 45.3K $70K +$70K $1.53 2